Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
This report contains market size and forecasts of Insomnia Treatment Drugs in Global, including the following market information:
- Global Insomnia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Insomnia Treatment Drugs market was valued at 3006.2 million in 2021 and is projected to reach US$ 3764 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Sleep Aids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insomnia Treatment Drugs include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insomnia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
- Prescription Sleep Aids
- Over the Counter (OTC) Sleep Aids
Global Insomnia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Global Insomnia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Insomnia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Insomnia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Insomnia Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F.Hoffman La-Roche AG
- Merck & Co. Inc.
- Mylan N.V.
- Pfizer, Inc.
- Pernix Therapeutics
- Sanofi S.A.
- Takeda Pharmaceutical Company Ltd.
- Sumitomo Dainippon Pharma Co., Ltd
- Teva Pharmaceutical Industries Ltd.
- Vanda Pharmaceuticals, Inc.
